1. Home
  2. Stock quotes
  3. Y-mAbs Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Y-mAbs Therapeutics logo
Y-mAbs Therapeutics YMAB
$ 12.95 1.01%
mail-toReport an Error

Quarterly report 2024-Q2
added 08-12-2024

report update icon

Y-mAbs Therapeutics EV/EBITDA Ratio 2011-2024 | YMAB

Annual EV/EBITDA Ratio Y-mAbs Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.09 -13.2 -11.8 -10.1 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.09 -13.2 -9.3